E-LIB Suche - Ergebnisse für: Alami, Negar N.

1

Pharmacokinetics, Tolerability, and Safety of Glecaprevir/P..:

Kalluri, Hari V. ; Oberoi, Rajneet K. ; Chen, Qian...
Clinical Pharmacology in Drug Development. 12 (2023) 10 - p. 945-955 , 2023

Link: https://doi.org/10.1002/..

2

Phase 1 study of safety, pharmacokinetics, and antiviral ac..:

Shebley, Mohamad ; Wang, Stanley ; Ali, Izna...
Pharmacology Research & Perspectives. 11 (2022) 1 - p. , 2022

Link: https://doi.org/10.1002/..

3

Ibrutinib for Hospitalized Adults With Severe Coronavirus D..:

Coutre, Steven E ; Barnett, Christopher ; Osiyemi, Olayemi...
Open Forum Infectious Diseases. 9 (2022) 5 - p. , 2022

Link: https://doi.org/10.1093/..

4

Safety and efficacy of glecaprevir/pibrentasvir in patients..:

Grebely, Jason ; Dore, Gregory J. ; Alami, Negar N....
International Journal of Drug Policy. 66 (2019) - p. 73-79 , 2019

Link: https://doi.org/10.1016/..

5

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir an..:

Grebely, Jason ; Puoti, Massimo ; Wedemeyer, Heiner...
Open Forum Infectious Diseases. 5 (2018) 11 - p. , 2018

Link: https://doi.org/10.1093/..

6

Change in the hepatic profile of hepatitis C virus genotype..:

Waked, Imam ; Esmat, Gamal ; Fouad, Rabab...
Journal of Medical Virology. 90 (2018) 11 - p. 1739-1744 , 2018

Link: https://doi.org/10.1002/..

7

Serologic Follow-up of Middle East Respiratory Syndrome Cor..:

Al Hosani, Farida Ismail ; Kim, Lindsay ; Khudhair, Ahmed...
Clinical Infectious Diseases. 68 (2018) 3 - p. 409-418 , 2018

Link: https://doi.org/10.1093/..

8

Transmission of Middle East Respiratory Syndrome Coronaviru..:

Hunter, Jennifer C. ; Nguyen, Duc ; Aden, Bashir...
Emerging Infectious Diseases. 22 (2016) 4 - p. 647-656 , 2016

Link: https://doi.org/10.3201/..

9

Response to Emergence of Middle East Respiratory Syndrome C..:

Al Hosani, Farida Ismail ; Pringle, Kimberly ; Al Mulla, Mariam...
Emerging Infectious Diseases. 22 (2016) 7 - p. 1162-1168 , 2016

Link: https://doi.org/10.3201/..

10

Evaluation of community‐based treatment for drug‐resistant ..:

Cavanaugh, Joseph S. ; Kurbatova, Ekaterina ; Alami, Negar N....
Tropical Medicine & International Health. 21 (2015) 1 - p. 131-139 , 2015

Link: https://doi.org/10.1111/..

11

Phase 1 study of safety, pharmacokinetics, and antiviral ac..:

Shebley, Mohamad ; Wang, Stanley ; Ali, Izna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764278/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Ibrutinib for Hospitalized Adults with Severe COVID-19 Infe..:

Coutre, Steven E ; Barnett, Christopher ; Osiyemi, Olayemi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992313/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir an..:

Grebely, Jason ; Puoti, Massimo ; Wedemeyer, Heiner...
info:eu-repo/semantics/altIdentifier/pmid/30430131. , 2018

Link: http://hdl.handle.net/11..

14

Change in the hepatic profile of hepatitis C virus genotype..:

Waked, Imam ; Esmat, Gamal ; Fouad, Rabab...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767547/. , 2018

Link: http://www.ncbi.nlm.nih...

15

Response to Emergence of Middle East Respiratory Syndrome C..:

Al Hosani, Farida Ismail ; Pringle, Kimberly ; Al Mulla, Mariam...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918155/. , 2016

Link: http://www.ncbi.nlm.nih...